Category: Adamas Skyrockets on FDA Approval for Dyskinesia Treatment – Biotech Movers

Adamas Skyrockets on FDA Approval for Dyskinesia Treatment – Biotech Movers

  1. Adamas Skyrockets on FDA Approval for Dyskinesia Treatment – Biotech Movers  TheStreet.com
  2. Adamas Pharmaceuticals (ADMS) Stock Soars 41% After FDA Approval  Nasdaq
  3. Adamas Pharma’s Gocovri Approved, A Welcome Addition To Parkinson’s Treatments  Benzinga
  4. Full coverage

from Business – Google News https://www.thestreet.com/story/14284126/1/adamas-skyrockets-on-fda-approval-for-dyskinesia-treatment-biotech-movers.html

Advertisements

Adamas Skyrockets on FDA Approval for Dyskinesia Treatment – Biotech Movers

  1. Adamas Skyrockets on FDA Approval for Dyskinesia Treatment – Biotech Movers  TheStreet.com
  2. What Adamas FDA Approval Really Means  Seeking Alpha
  3. Adamas Pharma’s Gocovri Approved, A Welcome Addition To Parkinson’s Treatments  Benzinga
  4. Full coverage

from Business – Google News https://www.thestreet.com/story/14284126/1/adamas-skyrockets-on-fda-approval-for-dyskinesia-treatment-biotech-movers.html

Adamas Skyrockets on FDA Approval for Dyskinesia Treatment – Biotech Movers

  1. Adamas Skyrockets on FDA Approval for Dyskinesia Treatment – Biotech Movers  TheStreet.com
  2. This Biotech Rose To A 19-Month High — What’s Prodding Shares?  Investor’s Business Daily
  3. Mid-Morning Market Update: Markets Open Higher; Big Lots Profit Tops Estimates  Nasdaq
  4. Full coverage

from Business – Google News https://www.thestreet.com/story/14284126/1/adamas-skyrockets-on-fda-approval-for-dyskinesia-treatment-biotech-movers.html